Polymyxin B hemoperfusion in sepsis: growing body of evidence and occasional conflicting results.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. TIGRIS and EUPHRATES eventually join and provide new evidence: a narrative review of the polymyxin B hemoperfusion.Journal of intensive care · 2025
   Review
2. Treatment approaches to horses with acute diarrhea admitted to referral institutions: A multicenter retrospective study.PloS one · 2024
   Article
3. Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements.World journal of critical care medicine · 2023
   Review
4. Early use of endotoxin absorption by oXiris in abdominal septic shock: A case report.Medicine · 2020
   Article
5. Anti-endotoxin Properties of Polymyxin B-immobilized Fibers.Advances in experimental medicine and biology · 2019
   Review
6. Regional citrate-calcium anticoagulation during polymyxin-B hemoperfusion: A case series.The International journal of artificial organs · 2018
   Article
7. In Vitro Study of Endotoxin Adsorption by a Polymyxin B-Immobilized Fiber Column.Blood purification · 2018
   Article
8. Escherichia coli outer membrane vesicles can contribute to sepsis induced cardiac dysfunction.Scientific reports · 2017
   Article
9. History and current status of polymyxin B-immobilized fiber column for treatment of severe sepsis and septic shock.Annals of gastroenterological surgery · 2017
   Review
10. Astragaloside IV Alleviates Lipopolysaccharide-Induced Acute Kidney Injury Through Down-Regulating Cytokines, CCR5 and p-ERK, and Elevating Anti-Oxidative Ability.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article

Corrections and comments

• Comment on
  Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.2015

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as